Responses
Commentary
General medicine
In stable COPD, long-acting muscarinic antagonist plus long-acting beta-agonists resulted in less exacerbations, pneumonia and larger improvement in FEV
1
than long-acting beta-agonists plus inhaled corticosteroids
Compose a Response to This Article
Other responses
No responses have been published for this article.